Navigation Links
ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomycin Hydorchloride
Date:8/4/2009

on ViroPharma and our business.

Certain statements in this press release may contain forward-looking statements that involve a number of risks and uncertainties. There can be no assurance that the FDA will provide the opportunity for further public discussion, that the FDA will agree with the positions stated in ViroPharma's Vancocin-related submissions or that ViroPharma's efforts to oppose the FDA's December 2008 bioequivalence guidance for Vancocin through in vitro dissolution testing will be successful. We cannot predict the timeframe in which the FDA will make a decision regarding either ViroPharma's citizen petition for Vancocin or the approval of generic versions of Vancocin. If we are unable to change the FDA's December 2008 bioequivalence guidance for Vancocin, the threat of generic competition will be high. The entry of competing generic products will significantly affect our sales of Vancocin and our financial performance. Our actual results could differ materially from those results expressed in, or implied by, these forward-looking statements. These factors, and other factors, including, but not limited to those described in ViroPharma's annual report on Form 10-K and quarterly reports on Form 10-Q filed with the Securities and Exchange Commission during 2009 could cause future results to differ materially from the expectations expressed in this press release. The forward-looking statements contained in this press release may become outdated over time. ViroPharma does not assume any responsibility for updating any forward-looking statements.


'/>"/>
SOURCE ViroPharma Incorporated
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. ViroPharma Incorporated Reports Second Quarter 2009 Financial Results
2. ViroPharma to Release 2009 Second Quarter Financial Results on July 29, 2009
3. ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors
4. ViroPharma Announces Meeting of FDA Advisory Committee for Pharmaceutical Science and Clinical Pharmacology on Bioequivalence Recommendations for Oral Vancomycin Hydrochloride Products
5. ViroPharma to Present at Two May Healthcare Conferences
6. ViroPharma to Present at the Cowen & Company 29th Annual Healthcare Conference
7. ViroPharma to Host Investor Teach-In Educational Symposium on Hereditary Angioedema
8. ViroPharma to Release 2008 Fourth Quarter and Full Year Financial Results on February 24, 2009
9. ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients
10. ViroPharma to Present at the 27th Annual J.P. Morgan Healthcare Conference
11. ViroPharma Provides Update on Vancocin(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... key decisionmakers for nearly half of all hospital admissions, ... health care costs, according to a new report from ... the ER increased by 17 percent over seven years, ... between 2003 and 2009. Hospital inpatient care is ... 31 percent of the nation,s health care expenses. , ...
(Date:5/19/2013)... NJ (PRWEB) May 20, 2013 The ... joined Summit Medical Group: David A. Abrutyn, M.D., Robert ... continue to see patients at their current location, 215 ... Abrutyn, M.D., has expertise in sports medicine, with emphasis ... treats pediatric, adolescent, and adult patients for a wide ...
(Date:5/19/2013)... SUNDAY, May 19 (HealthDay News) -- Although spring arrived ... the summer allergy season will still be strong, according ... at Birmingham. Dr. Richard Waguespack, clinical professor in ... often results in a robust summer allergy season. However, ... as sneezing, wheezing and coughing, he added. "Tree ...
(Date:5/19/2013)... Omaha, Nebraska is a city of diversity, economic growth ... the lowest unemployment rates in the country. Forbes Magazine distinguished ... Business and Careers and it consistently scores high on many ... in the nation and is a strong business leader thanks ... Editions TV are pleased to announce air dates ...
(Date:5/19/2013)... 2013 Today, Zane Benefits, Inc. ... health insurance . Zane Benefits, which provides comprehensive ... benefits, is the leader in health care reform, ... arrangements . , According to Zane Benefits’ website, ... know the value of small business health insurance ...
Breaking Medicine News(10 mins):Health News:ER docs are key to reducing health care costs 2Health News:ER docs are key to reducing health care costs 3Health News:Summit Medical Group Welcomes the Center for Orthopedic Care 2Health News:Summit Medical Group Welcomes the Center for Orthopedic Care 3Health News:Managing Seasonal Allergies 2Health News:Editions TV Announces May Air Dates for Omaha, Nebraska 2Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 2Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 3
... physical and psychological function after traumatic brain injury is closely ... edition of Deutsches rzteblatt International ( Dtsch Arztebl ... von Cramon conclude that this is not the case. ... and is mostly caused by traffic accidents, falls, or blows ...
... grown over the past decade. A new study conducted ... The Research Institute at Nationwide Children,s Hospital has found ... increased as well. The study found that more than ... emergency departments between 1990 and 2007, increasing nearly 50 ...
... U.S. Apple Association announces new ... Vienna, ... and the media, the U.S. Apple Association (USApple) has entered the world of social networking, launching ... page on Facebook and profile on twitter went live Monday, joining a number of other produce ...
... injections in joint fluid may be beneficial ... therapy directed to joint fluid may help regenerate damaged ... German researchers. , Their study aimed to examine the ... progenitor cells, or CPCS -- that is present in ...
... , ... as Possible Solution for Back Pain Sufferers , ... Monroe, Mich. (Vocus) March 30, 2010 -- Those with aching backs might ... most homeowners consider their personal style, color schemes and price range, but many don,t take ...
... ... Athletes Can Benefit From A Posture Brace ( www.posturenow.com ) , ... (PRWEB) March 30, 2010 -- Within ... Stars, the blogosphere was abuzz with comments about Chad Ochocinco’s poor posture. , , ...
Cached Medicine News:Health News:New national study examines weight training-related injuries 2Health News:New national study examines weight training-related injuries 3Health News:Get your Virtual ‘Apple a Day' 2Health News:Hormone Replacement Might Relieve Arthritis 2Health News:Proper Home Dcor May Assist in Alleviating Back Pain 2Health News:Proper Home Dcor May Assist in Alleviating Back Pain 3Health News:Dancing With The Slouching Stars: Chad Ochocinco Fumbles When It Comes To Posture 2
(Date:5/17/2013)... RONKONKOMA, N.Y. , May 17, 2013  Lakeland ... global manufacturer of protective clothing for industry, healthcare and ... levels, will release its financial results for the fiscal ... on Tuesday, May 21, 2013 at stock market close ... day at 4:30 p.m. eastern. (Logo: ...
(Date:5/17/2013)... May 17, 2013  Technology advances have had ... Faced with a constantly evolving communication environment, companies ... for communicating with internal executives. It is challenging, ... strategies, tactics and tools that are part of ... new study, Best Practices, LLC explores the various ...
(Date:5/17/2013)...  Sony Biotechnology Inc. ("Sony") today announced the launch ... will be exhibiting and taking orders for this system ... San Diego Convention Center in ... 20 - 22.  The SP6800 Spectral ... technologies into new and novel functionalities for the immunology, ...
Breaking Medicine Technology:Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call 2Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2
... 25, 2011 Techne Corporation,s (NASDAQ: TECH ) ... the following highlights: First quarter earnings were $27.5 ... quarter grew 13.2% to $30.0 million or $.81 per diluted ... upon the sale of inventory that was written-up to fair ...
... 25, 2011 Reportlinker.com announces that a ... its catalogue: GPCRs ... Novel GPCR Targets are Increasing ... GPCRs in Drug Discovery - Efforts to ...
Cached Medicine Technology:Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 2Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 3Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 4Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 5Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 6Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 7Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 8GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing 2GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing 3GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing 4GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing 5GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing 6GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing 7GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing 8GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing 9GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing 10GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing 11GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing 12GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing 13GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing 14
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: